Risici ved brug af selektive serotoningenoptagelseshæmmere til gravide

Terje Martens, Per Damkier, Poul Videbech

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

Depression in pregnancy is common and may have serious consequences for the mother and foetus when untreated.
In this review, we discuss selective serotonin reuptake inhibitor (SSRI) intake in pregnancy, which has been associated with increased risk of several unwanted events. However, the evidence indicating a causal relationship between the intake of SSRI in pregnancy and most investigated outcomes is of very low certainty. Confounding by indication likely accounts for most of the observed correlations. If, for any outcomes, an increased risk exists, the number needed to harm is high, and the clinical significance is unclear.
Bidragets oversatte titelThe risks of selective serotonin reuptake inhibitor intake in pregnancy
OriginalsprogDansk
ArtikelnummerV06190338
TidsskriftUgeskrift for Laeger
Vol/bind182
Udgave nummer5
ISSN0041-5782
StatusUdgivet - 2020

Fingeraftryk

Dyk ned i forskningsemnerne om 'Risici ved brug af selektive serotoningenoptagelseshæmmere til gravide'. Sammen danner de et unikt fingeraftryk.

Citationsformater